Back
Amplify Treatments, Testing and Adv ETF Quote, Financials, Valuation and Earnings
Buy
59
GERM
Amplify Treatments, Testing and Adv ETF
Last Price:
19.06
Seasonality Move:
10.7%
7 Day Trial
ALL ACCESS PASS
$
7
Amplify Treatments, Testing and Adv ETF Price Quote
$19.06
-0.17 (0.49%)
(Updated: May 19, 2024 at 8:30 PM ET)
Amplify Treatments, Testing and Adv ETF Key Stats
Buy
59
Amplify Treatments, Testing and Adv ETF (GERM)
is a Buy
Day range:
$19.22 - $19.23
52-week range:
$15.67 - $21.48
Dividend yield:
1.34%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
274
Avg. volume:
2.3K
1-year change:
-6.86%
Market cap:
$0
Revenue:
$0
EPS:
$0
How Much Does Amplify Treatments, Testing and Adv ETF Make?
Data Unavailable
Is Amplify Treatments, Testing and Adv ETF Growing As A Company?
Data Unavailable
Amplify Treatments, Testing and Adv ETF Stock Price Performance
-
Did Amplify Treatments, Testing and Adv ETF Stock Go Up Last Month?
Amplify Treatments, Testing and Adv ETF share price went up by 16.27% last month -
Did GERM's Share Price Rise Over The Last Year?
GERM share price fell by -6.86% over the past 1 year
What Is Amplify Treatments, Testing and Adv ETF 52-Week High & Low?
-
What Is Amplify Treatments, Testing and Adv ETF’s 52-Week High Share Price?
Amplify Treatments, Testing and Adv ETF has traded as high as $21.48 over the past 52 weeks -
What Is Amplify Treatments, Testing and Adv ETF’s 52-Week Low Share Price?
Amplify Treatments, Testing and Adv ETF has traded as low as $15.67 over the past 52 weeks
Amplify Treatments, Testing and Adv ETF Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Amplify Treatments, Testing and Adv ETF?
Data Unavailable
Is Amplify Treatments, Testing and Adv ETF Cash Flow Positive?
Data Unavailable
Amplify Treatments, Testing and Adv ETF Return On Invested Capital
Data Unavailable
Amplify Treatments, Testing and Adv ETF Earnings Date & Stock Price
-
What Is Amplify Treatments, Testing and Adv ETF's Stock Price Today?
A single share of GERM can be purchased today for 19.23 -
What Is Amplify Treatments, Testing and Adv ETF’s Stock Symbol?
Amplify Treatments, Testing and Adv ETF trades on the nysearca under the ticker symbol: GERM -
When Is Amplify Treatments, Testing and Adv ETF’s Next Earnings Date?
The next quarterly earnings date for Amplify Treatments, Testing and Adv ETF is scheduled on May 20, 2024 -
When Is GERM's next ex-dividend date?
Amplify Treatments, Testing and Adv ETF's next ex-dividend date is March 26, 2024 -
How To Buy Amplify Treatments, Testing and Adv ETF Stock?
You can buy Amplify Treatments, Testing and Adv ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Amplify Treatments, Testing and Adv ETF Competitors
-
Who Are Amplify Treatments, Testing and Adv ETF's Competitors?
Below is a list of companies who compete with Amplify Treatments, Testing and Adv ETF or are related in some way:
Amplify Treatments, Testing and Adv ETF Dividend Yield
-
What Is GERM Dividend Yield?
Amplify Treatments, Testing and Adv ETF’s dividend yield currently is 1.34% -
What Is Amplify Treatments, Testing and Adv ETF’s Payout Ratio?
Amplify Treatments, Testing and Adv ETF’s payout ratio is 0% -
When Did Amplify Treatments, Testing and Adv ETF Last Pay A Dividend?
The latest dividend pay date is May 20, 2024 -
What Is Amplify Treatments, Testing and Adv ETF’s Dividend Per Share?
Amplify Treatments, Testing and Adv ETF pays a dividend of $0.00 per share
Amplify Treatments, Testing and Adv ETF Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable